Gossamer Bio GOSS

$ 0.69 3.82%

Quarterly report 2024-Q3
added 11-07-2024

Gossamer Bio Balance Sheet 2011-2024 | GOSS

Annual Balance Sheet Gossamer Bio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-28 M	-97 M	-151 M	-311 M	160 M	-105 M	5.72 M	-20 K	-	-	-	-	-
Long Term Debt	814 K	12 M	29.1 M	172 M	28.5 M	-	6.04 M	40 K	-	-	-	-	-
Long Term Debt Current	3.3 M	2.98 M	2.9 M	3.63 M	2.35 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	37.2 M	339 M	6.04 M	40 K	-	-	-	-	-
Total Current Liabilities	51.6 M	49.2 M	39.9 M	38.6 M	36.9 M	-	-	-	-	-	-	-	-
Total Liabilities	249 M	260 M	222 M	219 M	74.1 M	359 M	7.31 M	183 K	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.21 B	-1.03 B	-812 M	-578 M	-334 M	-154 M	-6.89 M	-123 K	-	-	-	-	-
Total Assets	312 M	272 M	344 M	539 M	427 M	239 M	445 K	60 K	-	-	-	-	-
Cash and Cash Equivalents	32.1 M	112 M	183 M	487 M	135 M	105 M	315 K	-	-	-	-	-	-
Book Value	62.8 M	12.1 M	121 M	321 M	352 M	-120 M	-6.86 M	-123 K	-	-	-	-	-
Total Shareholders Equity	62.8 M	12.1 M	121 M	321 M	352 M	-120 M	-6.86 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Gossamer Bio

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	814 K	3.63 M	6.44 M	9.22 M	12 M	14.8 M	17.6 M	29.2 M	29.1 M	29 M	28.9 M	28.8 M	28.7 M	28.7 M	28.7 M	28.7 M	28.5 M	28.5 M	28.5 M	28.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	297 M	292 M	233 M	249 M	243 M	245 M	248 M	260 M	267 M	262 M	265 M	222 M	217 M	212 M	210 M	219 M	219 M	219 M	219 M	74.1 M	74.1 M	74.1 M	74.1 M	21.1 M	21.1 M	21.1 M	21.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	20.3 M	17 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.24 B	-1.2 B	-1.25 B	-1.21 B	-1.16 B	-1.12 B	-1.08 B	-1.03 B	-976 M	-917 M	-861 M	-812 M	-755 M	-695 M	-635 M	-578 M	-578 M	-578 M	-578 M	-334 M	-334 M	-334 M	-334 M	-154 M	-154 M	-154 M	-154 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	351 M	373 M	259 M	312 M	348 M	182 M	220 M	272 M	324 M	246 M	295 M	344 M	387 M	433 M	482 M	539 M	539 M	539 M	539 M	427 M	427 M	427 M	427 M	239 M	239 M	239 M	239 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	28.5 M	86.9 M	38.9 M	32.1 M	82.6 M	37 M	65.2 M	112 M	153 M	94.3 M	139 M	183 M	214 M	343 M	440 M	487 M	486 M	486 M	486 M	135 M	135 M	135 M	135 M	105 M	105 M	105 M	105 M	315 K	-	-	-	60 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	54.1 M	81.5 M	26.7 M	62.8 M	105 M	-62.8 M	-28.5 M	12.1 M	56.4 M	-16.5 M	30.2 M	121 M	170 M	221 M	272 M	321 M	321 M	321 M	321 M	352 M	352 M	352 M	352 M	218 M	218 M	218 M	218 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	54.1 M	81.5 M	26.7 M	62.8 M	105 M	-62.8 M	-28.5 M	12.1 M	56.4 M	-16.5 M	30.2 M	121 M	170 M	221 M	272 M	321 M	321 M	321 M	321 M	352 M	352 M	352 M	352 M	-120 M	-120 M	-120 M	-120 M	-6.86 M	-	-	-	-123 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency